Combating AMR with Antimicrobial Peptides

A unique RNAi therapeutic to induce endogenous Antimicrobial Peptide Secretion against AMR infection

This technology releases a cocktail of natural antimicrobial peptides that are safe for the tissue and recalcitrant to the evolution of resistance.

  • Infection prevention
  • Alternative antimicrobials

  • Bacteria
  • Viruses

  • Human

Development stage:
  • Research
  • Development

  • Institute

  • License, Co-develop, Outsource, Joint Venture

We are initiating a new private venture, budding out of inStem (Academic Institute), looking for co-developers, and investors interested in the pre-clinical and phase-1 trials of our innovation.

A new venture budding out of inStem – developing RNAi therapies to combat AMR infections and accelerate wound-healing.

We are a team with translational research and commercialization experience in the domain of wound-healing, skin fibrosis, and allied diseases.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!